GLP-1s are not going anywhere pharma manufacturers continue to evolve their GLP-1/GIP product offerings (e.g., Eli Lillys Zepbound is the newest on the market), and the number of addressable indications is increasing (e.g., recent clinical evidence that may merit further FDA approval of GLP-1s for cardio-metabolic, nephrological and neurological indications)
You might not feel hungry, but your body still needs protein, fiber, healthy fats, vitamins, and minerals to stay alive
Because NAD+ and glutathione are nutrients and not drugs, there are no known negative side effects, and you dont need a medical prescription
Their advocacy is about ensuring that GP surgeries move beyond rigid protocols and adopt a more patient-centered approach
4 Acute liver diseases often result from hepatotropic virus infections, though drug-induced liver injury (DILI) is also becoming increasingly prevalent worldwide